FDA
Articles tagged with “FDA”
Ketamine Compounding Regulations in 2026: What Has Changed
An overview of the latest regulatory developments affecting compounded ketamine in 2026, including FDA enforcement updates, state-level changes, and the impact on patient access.
Esketamine: The S-Enantiomer Behind Spravato
A glossary entry on esketamine, the S-enantiomer of ketamine marketed as Spravato, covering its pharmacology, FDA approval, and clinical significance.
FDA Esketamine (Spravato) Updates
A summary of the latest FDA regulatory actions, label updates, and clinical developments related to esketamine (Spravato) for depression treatment.
Intranasal Ketamine and Esketamine (Spravato)
Intranasal ketamine and FDA-approved Spravato (esketamine): how dosing works, the REMS clinic visit, side effects, insurance coverage, and what to expect.
History of Ketamine
History of ketamine from 1962 synthesis to surgical anesthetic, Vietnam-era field use, club drug years, the depression discovery, and FDA approval of Spravato.
Is Ketamine Legal for Therapy?
A clear explanation of ketamine's legal status in the United States and internationally, including FDA-approved uses, off-label prescribing, and controlled substance classification.
Contact Ketamine Resource
Send corrections, partnership questions, or advertising inquiries.